Published on the Packaging World Web site
| October 31, 1997
FDA's Nonprescription Drugs Advisory Committee has recommended that labels of OTC pediatric analgesic and antipyretic drugs could contain directions for children down to two months of age.
A special warning could be included for parents of infants two to four months old to have a physician check for a more serious condition before administering the drug. The committee discussed labeling directions for both suspension liquids and double concentrated infant drops. Both formulations exist for products including Children's Tylenol Children's Motrin and Children's Advil. FDA has shown increasing interest in pediatric drug labeling. It has issued a proposed rule requiring testing of some prescription drugs for safety when used by children as well as appropriate dosages and labeling.
© Copyright 2015 Summit Media Group, Inc. This copy is for your personal, noncommercial use only. To order presentation-ready copies for distribution to your colleagues, clients or customers click HERE
or use the "Reprints" tool that appears next to any article. Visit www.summitreprints.com
for samples and additional information. Order a reprint or license this article now.